Abstract
Peripheral neuropathy is a serious diabetic complication. Delayed nerve regeneration in diabetic animal models suggests abnormalities in proliferation/differentiation of Schwann cells (SC). We recently reported that endothelins (ETs) regulate proliferation and phenotype in primary and immortalized SC (iSC). We now investigated changes in the effects of ETs on SC proliferation and signaling in nerve segments from streptozotocin-induced diabetic rats and in iSC exposed to high glucose. Cultured explants from diabetic rats displayed a delay in the time-course of [3H]-thymidine incorporation as well as enhanced sensitivity to endothelin-1 (ET-1) or insulin. iSC cultured in high (25 mM) glucose-containing media also exhibited higher [3H]-thymidine incorporation, along with an enhanced activation of p38 mitogen-activated protein kinase and phospholipase C in response to ET-1 or platelet-derived growth factor as compared to controls (5.5 mM glucose). These studies support an extra-vascular role of ETs in peripheral nerves and SC. The increased sensitivity to ET-1 in nerves and iSC exposed to high glucose may contribute to abnormal SC proliferation characterizing diabetic neuropathy.
Similar content being viewed by others
REFERENCES
Low, P. A., Tuck, R. R., and Takeuchi, M. 1987. Nerve microenvironments in diabetic neuropathy, in “Diabetic Neuropathy” (Dyck, P. J., Thomas, P. K., Asbury, A. K., Winegrad, A. I., and Porte, D., eds.) Saunders, Philadelphia, pp. 266-278.
Dyck, P. J. and Giannini, C. 1996. Pathological alterations in the diabetic neuropathies of humans: A review. J. Neuropathol. Exp. Neurol. 55:1181-1193.
Bradley, J. L., Thomas, P. K., King, R. H., Muddle, J. R., Ward, J. D., Tesfaye, S., Boulton, A. J., Tsigos, C., and Young, R. J. 1995. Myelinated nerve fiber regeneration in diabetic sensory polyneuropathy: Correlation with type of diabetes. Acta Neuropathol. (Berl) 90:03-10.
Terada, M., Yasuda, H., and Kikkawa, R. 1998. Delayed Wallerian degeneration and increased neurofilament phosphorylation in sciatic nerves of rats with streptozotocin-induced diabetes. J. Neurol. Sci. 155:23-30.
Van Gerven, J. M. and Tjon-A-Tsien, A. M. 1995. The efficacy of aldose reductase inhibitors in the management of diabetic complication. Comparison with intensive insulin treatment and pancreatic transplantation. Drugs Aging 6:9-28.
Scarpini, E., Conti, G., Chianese, L., Baron, P., Pizzul, S., Basellini, A., Livraghi, S., and Scarlato, G. 1996. Induction of p75NGFRin human diabetic neuropathy. J. Neurol. Sci. 135:55-62.
Kalichman, W. M., Powell, H. C., and Mizisin, A. P. 1998. Reactive, degenerative, and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy. Acta Neuropathol. 95:47-56.
Vinik, A. I. 1999. Diabetic neuropathy: Pathogenesis and therapy. Am. J. Med. 107:17S-26S.
Hopfner, R. L. and Gopalakrishman, V. 1999. Endothelin: Emerging role in diabetic vascular complications. Diabetologia 42:1383-1394.
Zochodne, D. W. and Cheng, C. 1999. Diabetic peripheral nerves are susceptible to multifocal ischemic damage from endothelin. Brain Res. 838:11-17.
Wilkins, P. L., Suchovsky, D., and Berti-Mattera, L. N. 1997. Immortalized Schwann cells express endothelin receptors coupled to adenylyl cyclase and phospholipase C. Neurochem. Res. 22:409-418.
Berti-Mattera, L. N., Wilkins, P., Harwalkar, S., Madhun, Z., Almhanna K., and Mattera, R. 2000. Endothelins Regulate Arachidonic Acid Release and Mitogen-Activated Protein Kinase Activity in Schwann Cells. J. Neurochem. 75:2316-2326.
Berti-Mattera, L. N., Wilkins, P., Harwalkar, S., and Almhanna, K. 2001. Proliferative and Morphological Effects of Endothelins in Schwann Cells: Roles of p38 Mitogen Activated Protein Kinase and Ca2+-independent Phospholipase A2.J. Neurochem. 79:1136-1148.
Goraya, T., Wilkins, P., Douglas, J., Zhou, J., and Berti-Mattera, L. N. 1995. Signal transduction alterations in peripheral nerves from streptozotocin-induced diabetic rats. J. Neurosci. Res. 41: 518-525.
Tonge, D., Edstrom, A., and Ekstrom, P. 1997. Use of explant cultures of peripheral nerves of adult vertebrates to study axonal regeneration in vitro. Progress in Neurobiology 54:459-480.
Lowry, O. H., Rosebrough, N. G., Farr, A. L., and Randall, R. G. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
Berti-Mattera, L. N., Wilkins, P. L., Madhun, Z., and Suchovsky, D. 1996. Phospholipase C and Adenylyl Cyclase Activities are Regulated by P2 Purinergic Agonists in Immortalized Schwann Cells. Biochem. J. 313:555-561.
Porter, S., Glaser, L., and Bunge, R. 1987. Release of autocrine growth factor by primary and immortalized Schwann cells. Proc. Natl. Acad. Sci. USA 84:7768-7772.
Laemmli, U. K. 1970. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227:680-685.
Svenningsen A. F. and Kanje, M. 1998. Regulation of Schwann cell proliferation in cultured segments of adult rat sciatic nerve. J. Neurosci. Res. 52:530-537.
Sondell, M., Fex-Svenningsen, A., and Kanje, M. 1997. The insulin-like growth factor I and II stimulate proliferation of different types of Schwann cells. NeuroReport 8:2871-2876.
Brennan, A., Dean, C. H., Zhang, A. L., Cass, D. T., Mirsky, R., and Jessen, K. R. 2000. Endothelins control the timing of Schwann cell generation in vitro and in vivo. Dev. Biol. 227: 545-557.
Pomonis, J. D., Rogers, S. D., Peters, C. M., Ghilardi, J. R., and Mantyh, P. W. 2001. Expression and localization of endothelin receptors: Implications for the involvement of peripheral glia in nociception. J Neurosci. 21:999-1006.
Jaffey, P. B. and Gelman, B. B. 1996. Increased vulnerability to demyelination in streptozotocin diabetic rats. J. Comp. Neurol. 373:55-61.
Tantuwaya, V. S., Bailey, S. B., Schmidt, R. E., Villadiego, A., Tong, J. X., and Rich, K. M. 1997. Peripheral nerve regeneration through silicone chambers in streptozocin-induced diabetic rats. Brain Res. 759:58-66.
Segal, S., Hwang, S. M., Stern, J., and Pleasure, D. 1984. Inositol uptake by cultured isolated Schwann cells. Biochem. Biophys. Res. Commun. 120:486-492.
Delaney, C. L., Russell, J. W., Cheng, H. L., and Feldman, E. L. 2001. Insulin-like growth factor-I and over-expression of Bcl-xL prevent glucose-mediated apoptosis in Schwann cells. J. Neuropathol. Exp. Neurol. 60:147-160.
Kuruvilla, R. and Eichberg, J. 1998. Depletion of phospholipid arachidonoyl-containing molecular species in a human Schwann cell line grown in elevated glucose and their restoration by an aldose reductase inhibitor. J Neurochem. 71:775-783.
Mizisin A. P., Li L., Perello, M., Freshwater, J. D., Kalichman, M. W., Roux, L., and Calcutt, N. 1996. Polyol pathway and osmo-regulation in JS1 Schwann cells grown in hyperglycemic and hyperosmotic conditions. Am. J. Physiol. 270:F90-F97.
Maekawa, K., Tanimoto, T., Okada, S., Suzuki, T., Suzuki, T., and Yabe-Nashimura, C. 2001. Expression of aldose reductase and sorbitol dehydrogenase genes in Schwann cells isolated from rat: Effects of high glucose and osmotic stress. Brain Res. Mol. Brain. Res. 87:251-256.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Almhanna, K., Wilkins, P.L., Bavis, J.R. et al. Hyperglycemia Triggers Abnormal Signaling and Proliferative Responses in Schwann Cells. Neurochem Res 27, 1341–1347 (2002). https://doi.org/10.1023/A:1021671615939
Issue Date:
DOI: https://doi.org/10.1023/A:1021671615939